results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
International Hospital” to the Group. The finance costs decreased in the amount of Baht 5.9 million or 15.3% which in line with the management of interest rate of long-term debts. - Income tax for Q1/2018 in the
. Administrative expenses decreased by Baht 7 million due mainly to a decrease in loss on exchange rate and repair & maintenance expenses. Share of loss from investment in associates decreased by Baht 20 million
increased at a rate of 3.2% over same period of last year which, in accordance with the policy, demonstrated the efficiency of Company cost control management. - Nevertheless, Company had incurred somewhat
in Hotel Business. Other Business growth came from the gain from the sale of investments, the share of profit from investment in food business (as invested in 1Q18), and gain on foreign exchange rate
than THB 160 million. (no collateral) Interest Rate : 3.50% per annum. Maturity : Not more than 3 years starting from August 25th, 2018 until August 24th, 2021. Interest Payment : Monthly Nature of
. - Interest income in Q2/2018 amounted 48.54 million baht increased by 29.77 million baht or 158.60% from 18.77 million baht in Q2/2017 due to increase in JV loan and the increase in intercompany interest rate
-year debentures with a par value of Baht 1,000 each, totaling Baht 1,500 million. The debentures will be mature on August 21, 2018. The coupon rate is 4.5% per annum. The objectives of issuing the
an decreasing of 46.51% from the total gross profit of 3rd quarter of year 2017 at Baht 159.97 million. The gross profit rate was decreasing from 14.76% to 8.39%. The profit detail was as follow; The